The India formulations business and rest-of-the-world segment provided a booster dose to Sun Pharmaceutical Industries Ltd.'s earnings for the December quarter, which saw sales from US and emerging markets record muted on-year growth and contraction on a quarterly basis. The India and rest-of-the-world operations helped Sun Pharma meet the Street's expectation for its December quarter earnings.
Share this Story:
